Elevated choline phospholipid metabolism is a hallmark of cancer. Here, we show that silencing choline kinase a (CKα), the rate-limiting enzyme in choline phospholipid biosynthesis, abrogates total choline (tCho) production from [2H9]-choline in patient-derived glioma models, indicating that tCho production from [2H9]-choline predominantly reflects CKα activity. Importantly, we show that [2H9]-choline metabolism to tCho serves to delineate tumor from normal brain in mice bearing orthotopic patient-derived low-grade gliomas. Furthermore, [2H9]-choline informs on response to therapy, at early timepoints when anatomical alterations cannot be detected, pointing to the ability of [2H9]-choline to assess pseudoprogression, which is a challenge in glioma imaging.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords